EU drug regulator approves use of Bavarian Nordic's mpox vaccine, Imvanex for adolescents: Copengagen, Denmark Saturday, September 21, 2024, 10:00 Hrs [IST] Bavarian Nordic A/S, a ...

The UN Children’s Fund, UNICEF, issued an urgent appeal on Friday for nearly $59 million to support efforts to halt the rapid ...

The European Medicines Agency (EMA) has approved the use of Bavarian Nordic’s mpox vaccine in adolescents, increasing the ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.

Rwanda has started a vaccination campaign against mpox with 1,000 doses of the vaccine it obtained from Nigeria under an ...

Bavarian's JYNNEOS has also been approved by the U.S. Food and Drug Administration (FDA) but only for adults 18 years and ...

African health-care workers fighting the rapid spread of a virulent mpox strain will learn how to effectively scratch under ...

Mpox, declared a global public health emergency by WHO, has disproportionately affected children and adolescents ...

Mpox (formerly known as monkeypox) is back in the news. As of early September, the World Health Organization has reported ...